期刊文献+

坎地沙坦酯对高血压合并高尿酸血症患者的尿微量蛋白排泄影响探讨 被引量:2

Effect of Candesartan on Urinary Microalbumin Excretion in Patients with Hypertension and Hyperuricemia
下载PDF
导出
摘要 目的分析坎地沙坦酯对高血压合并高尿酸血症患者的尿微量蛋白排泄影响。方法选取86例符合研究标准的高血压合并高尿酸血症患者作为案例进行对比研究。两组患者均在研究开始之前1周停用降压药物。常规组每天清晨口服左旋氨氯地平进行治疗,实验组每天清晨口服坎地沙坦酯进行治疗。总结并对比两组患者的治疗效果。结果治疗后实验组患者的SBP、DBP均优于常规组患者(P<0.05);治疗后,实验组患者多项尿微量蛋白值、血清肌酐数据均显著优于常规组,差异显著,具备统计学意义(P<0.05)。结论高血压合并高尿酸血症患者采用坎地沙坦酯的临床疗效突出,可以有效的改善尿微量蛋白排泄状况,能够有效的降压并控制尿微量蛋白排泄量,维护患者肾功能,提高患者康复效益,值得在临床中推广。 Objective To analyze the effect of candesartan ester on urinary microalbumin excretion in patientswith hypertension and hyperuricemia. Methods Eighty-six hypertensive patients with hyperuricemia were selectedand compared. The two groups stopped antihypertensive drugs 1 weeks before the start of the study. The routinegroup was given levoamlodipine every morning,,and the experimental group was given candesartan ester everymorning. The therapeutic effects of the two groups were summarized and compared. Results After treatment, the SBPand DBP of the experimental group were better than those of the conventional group(P<0.05). After treatment, the dataof Urinary Microprotein and serum creatinine in the experimental group were significantly better than those in theconventional group, with significant difference(P<0.05). Conclusion Candesartan axetil is effective in the treatmentof hypertension complicated with hyperuricemia. It can effectively improve the excretion of urinary microalbumin,reduce blood pressure and control the excretion of urinary microalbumin, maintain the renal function and improve therehabilitation benefit of patients. It is worth popularizing in clinic.
作者 李宪江 谭运新 LI Xian-jiang;TAN Yun-xin(Pukou Hospital of Nanjing,Nanjing,Jiangsu 210031)
出处 《智慧健康》 2018年第35期143-144,共2页 Smart Healthcare
关键词 坎地沙坦酯 高血压 高尿酸血症 尿微量蛋白 排泄影响 Candesartan ester Hypertension Hyperuricemia Urinary microalbumin Excretory effect
  • 相关文献

参考文献10

二级参考文献71

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1227
  • 2马虹.(8)血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂在心力衰竭治疗中的作用[J].中国循环杂志,2006,21(3):165-167. 被引量:10
  • 3中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].药品评价,2007,4(2):77-79. 被引量:43
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 6MAZZALI M, KANBAY M, SEGAL M S, et al. Uric acid and hypertension: cause or effect? [ J]. Curr Rheumatol Rep, 2010,12 (2) :108 -117.
  • 7蒲梦君.痛风合并糖尿病患者的I临床指标分析[J].中华临床医师杂志:电子版,2013,5(13):6118-6120.
  • 8Bruderer GS, Bodmer M, Jick SS, et al. Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study [J]. Ann Rheum Dis, 2015 ,74(9):1651-1658.
  • 9Xing SC, Wang XF, Miao ZM, et al . Association of an Exon SNP of SLC2A9 Gene with Hyperuricemia Complicated with Type 2 Diabetes Mellitus in the Chinese Male Han Population [J]. Cell Biochem Biophys, 2014, 71(3) : 1335-1339.
  • 10Assal HS, Tawfeek S, Rasheed EA, et al . Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunc- tion in type 2 diabetes mellitus [J]. Clin Med Insights Endocrinol Diabetes, 2013, 6 (6) : 7-13.

共引文献150

同被引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部